Xu et al[103] found that overexpression of SLC7A11 led to a reduced immune cell infiltration in tumor tissues, an impaired antigen-presenting cell function, and suppressed anti-tumor immune responses. The gene discussed is SLC7A11; the disease is neoplasm.